Best Ophthalmologists for Retinopathy Of Prematurity (ROP) Screening & Treatment in Delhi NCR, India

Retinopathy of prematurity (ROP) is an eye disease affecting premature infants in which the retinal blood vessels develop abnormally, potentially damaging the light-sensitive tissue at the back of the eye. Without timely detection and appropriate management, it can progress to retinal detachment and irreversible vision impairment.

Because ROP occurs in newborns who cannot report visual symptoms, the condition is typically detected through screening rather than by observable signs in the infant; in advanced stages, parents or caregivers may notice a lack of visual tracking, an abnormal white reflex in the pupil (leukocoria), or an inward or outward eye turn (strabismus). Severe, untreated ROP carries the risk of retinal detachment, which can cause permanent blindness in the affected eye. The presence or absence of these signs alone is not sufficient to establish a diagnosis or determine disease severity, which requires formal ophthalmic examination.

ROP is diagnosed through indirect ophthalmoscopy performed by a trained specialist, who dilates the infant's pupils to examine the retina directly and classify the disease using a standardized international staging system (Stages 1–5) based on the location of abnormal vessel growth (zones I–III), the extent of retinal involvement (clock hours), and the presence of "plus disease" — a marker of arterial tortuosity and venous dilation indicating active, aggressive disease. Screening timing is guided by gestational age and birth weight, with the first examination typically recommended between 4 and 6 weeks after birth or at 31–33 weeks postmenstrual age, whichever comes later. The decision on whether and when to intervene depends entirely on the stage, zone, and plus disease status as determined by the examining clinician.

Treatment approach is determined by the stage and zone of ROP identified at examination and is not required for all affected infants — many mild cases (Stage 1 or 2 without plus disease) resolve spontaneously and are managed with close monitoring. When treatment is indicated, laser photocoagulation of the peripheral avascular retina is the long-established standard of care, while intravitreal injections of anti-VEGF agents have become an increasingly used alternative or adjunct, particularly for aggressive posterior ROP. Advanced cases involving retinal detachment (Stages 4–5) may require surgical intervention such as scleral buckling or vitrectomy, though outcomes at these stages are significantly less predictable and depend on the individual clinical picture.

For infants with mild ROP (Stages 1–2, zone II or III, without plus disease), careful observation with scheduled repeat retinal examinations is a legitimate and commonly used management strategy, as spontaneous regression occurs in many cases. Intravitreal anti-VEGF injections represent a pharmacological — though still procedural — option that avoids laser surgery in select cases. There is no lifestyle-based intervention that treats or reverses ROP once it has developed; all management pathways require ongoing specialist supervision.

Retinopathy of Prematurity (ROP) Screening & Treatment may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.

ROP is evaluated and managed by a pediatric ophthalmologist or a vitreoretinal surgeon with specific experience in neonatal retinal disease; in neonatal intensive care settings, this specialist works closely with a neonatologist and the broader neonatal care team. For advanced or surgical cases, a vitreoretinal surgeon experienced in pediatric retinal detachment repair is typically involved.

When comparing care options, look for a center with dedicated neonatal ophthalmology screening protocols, a vitreoretinal surgeon experienced specifically in pediatric ROP management, and clear arrangements for structured follow-up, since the condition can progress rapidly and missed examinations can have serious consequences. Access to both laser and anti-VEGF treatment capabilities, as well as surgical backup for advanced disease, is an important indicator of a comprehensive program.

Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.

Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.